NeuLumEX and Liquid Polibar Plus are expected to be out of stock in May 2024 and August 2024, respectively. Bracco Diagnostics will no longer be producing NeuLumEX ™ (barium sulfate) Suspension, (0.1% ...

Ryplazim is supplied in a 50mL single-dose vial containing 68.8mg of plasminogen as a lyophilized powder for intravenous use after reconstitution. Kedrion Biopharma has resolved its supply issue for ...

Ingrezza Sprinkle capsules can be opened and sprinkled over a bowl containing a small amount of soft food. The Food and Drug Administration (FDA) has approved Ingrezza ® Sprinkle (valbenazine) for the ...

Tivdak is a tissue factor-directed antibody and microtubule inhibitor conjugate. The Food and Drug Administration (FDA) has granted full approval to Tivdak ® (tisotumab vedotin-tftv) for the treatment ...

Results showed a reduction in annualized bleeding rate after a single infusion of fidanacogene elaparvovec compared with ...

The nasal spray product delivers 10mg of naloxone hydrochloride in a single dose. The Food and Drug Administration (FDA) has approved Rezenopy (naloxone hydrochloride) nasal spray for the ...

Pregnant patients should discontinue use of thiopurines if they develop intrahepatic cholestasis of pregnancy. The use of thiopurines (eg, azathioprine, 6-mercaptopurine, and 6-thioguanine) by ...

Ojemda is the first FDA-approved systemic therapy for pediatric LGG patients with BRAF rearrangements, including fusions. The Food and Drug Administration (FDA) has granted accelerated approval to ...

Tarlatamab is an investigational first-in-class, bispecific T-cell engager immunotherapy designed to target delta-like ligand 3 on small cell lung cancer (SCLC) cells and CD3 on T cells. The ...

Credit: Getty Images The average financial impact of a health care breach is now $11 million, which far exceeds the spending required to get proper security, cybersecurity specialist says. A recent ...

Credit: X4 Pharmaceuticals. The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 4WHILM trial. Findings showed mavorixafor was associated with statistically ...

Credit: Getty Images. Revenue cycle management and clinical workflow optimization remain top areas of investment. Surveys suggest that health care organizations and patients have come to appreciate ...